• PHP74 Submission of New Drug Reimbursement and Pricing Applications to National Health Insurance (NHI) of Taiwan, Meeting Outcomes of the Drug Benefit Committee

    Nov 1, 2012, 00:00

  • PCV74 Economic Evaluation of Cardio Incode, A Genetic Platform for the Assessment of Ischemic Heart Disease Risk

    Nov 1, 2012, 00:00

  • PHP85 The Use of Biomarkers in Cancer Trials in Asia

    Nov 1, 2012, 00:00

  • Editorial Board

    Nov 1, 2012, 00:00

  • PDB10 Clinical Survey to Assess Outcomes in Diabetes Patients Using Pen Needles of Different Lengths

    Nov 1, 2012, 00:00

  • PHP168 Calculated Forecast for Technical Obsolescence in Computerised Tomography Equipment

    Nov 1, 2012, 00:00

  • PIH20 Cost-Effectiveness of Supplemental N-3 in Total Parenteral Nutrition Therapy in the Italian, French, German and UK Context- A Discrete Event Simulation Model

    Nov 1, 2012, 00:00

  • PDB59 Content Validity of a New Patient-Reported Outcome Instrument to Assess Hypoglycemia- The Hypoglycemia Perspectives Questionnaire

    Nov 1, 2012, 00:00

  • PRM59 Methods for Discounting in Economic Evaluation; An Empirical Comparison of Preferences in Money and Quality of Life

    Nov 1, 2012, 00:00

  • PMH53 Preventing Alzheimer Disease- Is There a Place for Cost-Effective Interventions? Dynamic Modeling Applied to a Pan European Analysis

    Nov 1, 2012, 00:00

  • PCN118 Impact of Bone Metastases on Quality of Life in Patients With Castration-Resistant Prostate Cancer (CRPC) at High Risk for Developing Bone Metastases

    Nov 1, 2012, 00:00

  • PCV76 Standard Costs and Resources Allocation in Attainment of Target Lipid Levels among Experienced Statin Users- Results From the STAR Study (Statins Target Assessment in Real Practice)

    Nov 1, 2012, 00:00

  • PND57 A Measure of Carer Quality of Life in Parkinson's Disease (PDQ-Carer)- Development and Validation of a Summary Index Score

    Nov 1, 2012, 00:00

  • PRM136 A Utility Single Score Derived From Short Form-36 and Health Assessment Questionnaire in Patients With Antiphospholipid Antibody Syndrome- A Methodolodical Proposal

    Nov 1, 2012, 00:00

  • PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)

    Nov 1, 2012, 00:00

  • PSU18 Assessment of the Resource Use and Costs Associated With Parathyroidectomy Surgery for Secondary Hyperparathyroidism in End Stage Renal Disease in the UK

    Nov 1, 2012, 00:00

  • PMS76 Patient Access to Biologics in Rheumatoid Arthritis- The Views of Health Care Stakeholders in Portugal

    Nov 1, 2012, 00:00

  • PGI17 Cost-Effectiveness of Telaprevir With Peginterferon and Ribavirin for Treatment-Naive Patients Chronically Infected With HCV of Genotype 1 in Japan

    Nov 1, 2012, 00:00

  • PIH5 Provider Payment and Cost of Treatment for Complicated Delivery Care- Evidence From Case Studies in Indonesia

    Nov 1, 2012, 00:00

  • PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai Area

    Nov 1, 2012, 00:00

  • PRS5 Cost Analysis of Childhood Asthma in Iran- A Cost Evaluation Based on Referral Center Data for Asthma Allergies

    Nov 1, 2012, 00:00

  • PSS7 Cost Effectiveness Analysis of Community Screening for Glaucoma in India

    Nov 1, 2012, 00:00

  • PSY9 Real-Life Cost-Analyses of Chronic Low-Back Pain Patients With Neuropathic Pain Components in Denmark

    Nov 1, 2012, 00:00

  • PSY49 Treatment Patterns in Psoriatic Arthritis (PSA) Patients Newly Initiated on Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

    Nov 1, 2012, 00:00

  • PHP58 Data Disclosure an Ongoing Process Towards More Transparency

    Nov 1, 2012, 00:00

  • PDB15 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus Throughout the World- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHS56 Evaluation of Telemedicine Program (ITHACA)- Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence

    Nov 1, 2012, 00:00

  • PGI29 Cost of Chronic Hepatitis C (HCV) in Poland – Health Care Professionals Survey

    Nov 1, 2012, 00:00

  • PND65 Spanish Neurology Therapeutic Society Guidelines for the Treatment of Relapsing Remitting MS- Are They Followed by Spanish Neurologists?

    Nov 1, 2012, 00:00

  • PHP96 Evidence Based Structural Reform in the Provision of Hospital Care- The Case Study of Merging Two Institutions in Hungary

    Nov 1, 2012, 00:00

  • PR2 A Feasibility Study of Preference-Based Health-Related Quality of Life Measures on Patients With Irritable Bowel Syndrom in Taiwan

    Nov 1, 2012, 00:00

  • PHP16 Removing the Barrier of Cost to Smoking Cessation Medications Under the Affordable Care Act of 2010

    Nov 1, 2012, 00:00

  • PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands- a Real-Life Study

    Nov 1, 2012, 00:00

  • PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status- An Analysis of United States National Registry Data 2000-2009

    Nov 1, 2012, 00:00

  • PHP84 The Economic Health Value from Rx to OTC Switch in Greece

    Nov 1, 2012, 00:00

  • PRS29 Queuing Statistical Model - A New Tool for Preliminary Cost-Effectiveness Assessments

    Nov 1, 2012, 00:00

  • PCV2 Evaluation of Stroke Risk Associated With Antipsychotic Use in Patinets with Cardiovascular Diseases

    Nov 1, 2012, 00:00

  • PND33 Cost-Effectiveness Analysis of Genetic Testing of First-Degree Relatives at Risk of Sudden Cardiac Death Due to Gene-Related Cardiopathies in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PND72 Access, Uptake and Utilization Management of Multiple Sclerosis Products in the United States

    Nov 1, 2012, 00:00

  • PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and Kor ...

    Nov 1, 2012, 00:00

  • CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?

    Nov 1, 2012, 00:00

  • PDB20 Estimating the Direct Medical Costs Associated with Diabetes-Related Complications in Indonesia

    Nov 1, 2012, 00:00

  • PRS19 Cost-Benefit Analysis of Tiotropium and Salmeterol Treatment Compare to Usual Practice on Sample of Employed Economicaly Active COPD Patients in Ukraine

    Nov 1, 2012, 00:00

  • PRS32 Allergy Patients Treated With Immunotherapy Experience Increased Quality of Life and Fewer Sick Days After One Year

    Nov 1, 2012, 00:00

  • PMD63 A Review of Economic Evaluation Models for Cardiac Resynchronization Therapy With Implantable Cardioverter Defibrillators in Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PRM39 Survival Curve Convergences and Crossing- A Threat to Validity of Meta-Analysis?

    Nov 1, 2012, 00:00

  • PSY14 Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukaemia- A Probabilistic Decision Model

    Nov 1, 2012, 00:00

  • PMD75 Does Presenting Follow-Up Test Information Affect People's Preferences for Colorectal Cancer Screening Tests? A Discrete Choice Experiment

    Nov 1, 2012, 00:00

  • PIH3 Pregnancy Outcomes Folowing Exposure to Serotonin Reuptake Inhibitors- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PDB31 The Relationship Between the Cost of Disease and the Presence of Ophthalmic Complications in Type 2 Diabetes Mellitus is Determined via the Concomitant Complications Other Than Ophthalmic Complications

    Nov 1, 2012, 00:00

  • PMS9 Budget Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in a Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain

    Nov 1, 2012, 00:00

  • PIN85 Burden of Methicillin-Resistant Staphylococcus Aureus Bacteremia on Hospitals in the United States- Results From a National Database

    Nov 1, 2012, 00:00

  • PRM10 Overview of the Prolabels Database Six Years After Its Implementation

    Nov 1, 2012, 00:00

  • PCN9 Epidemiology of Venous Thromboembolism Among Cancer Patients in Taiwan

    Nov 1, 2012, 00:00

  • PCN111 The Value of Personalizing Medicine- Medical Oncologists' and Patients' Perspectives on Genomic Testing of Breast Tumours in Chemotherapy Treatment Decisions

    Nov 1, 2012, 00:00

  • PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C- A Greek National Health System Perspective

    Nov 1, 2012, 00:00

  • PRM71 Differential Time Preference for Money, Life Years and Quality of Life- An Empirical Pilot Study

    Nov 1, 2012, 00:00

  • PSY18 The Future Characteristics of Bypassing Agents Improving Haemophilia Inhibitor Patients Care From an Economic and Health Related Quality of Life Perspective

    Nov 1, 2012, 00:00

  • PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in England

    Nov 1, 2012, 00:00

  • PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada

    Nov 1, 2012, 00:00

  • PHP24 Assessment of the in Excess NHI-Covered Medications of Outpatients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PSY22 A Cost-Effectiveness Analysis of Parecoxib in the Management of Post-Operative Pain in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PHS8 Use of Health Care Administrative Databases to Estimate Incidence of Foot Complications in Diabetes Patients

    Nov 1, 2012, 00:00

  • PRM89 Standardizing the Metric and Increasing the Efficiency of Physical Functioning Outcomes Measurement

    Nov 1, 2012, 00:00

  • PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid Leukaemia

    Nov 1, 2012, 00:00

  • PGI33 Assessing Gas-Related Symptoms and Their Associated Impact on the Daily Life of the General Population and Irritable Bowel Syndrome Patients- International Development of a Questionnaire–Qualitative Steps

    Nov 1, 2012, 00:00

  • PIN77 Elicitation of Health-Related Quality of Life Concepts Associated With Cytomegalovirus in Transplant Recipients

    Nov 1, 2012, 00:00

  • PRS9 Comparison of Knowledge About Tuberculosis among Libyan and Non Libyan TB Patients in North East Libya

    Nov 1, 2012, 00:00

  • VA2 Correlates of Protection for Vaccines- When Does a Correlate Equal Protection?

    Nov 1, 2012, 00:00

  • PHP130 Guidelines Without Guidan The Case of Epidemiological Data Beyond Clinical Trials

    Nov 1, 2012, 00:00

  • PND46 Relationship Between Patient Adherence to Treatment and Spanish Hospital Pharmacy'S Unmet Needs for the Management of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PIN89 European Reference Pricing for Vaccines in Germany- Mechanics and Effects

    Nov 1, 2012, 00:00

  • PCV91 The Impact of Atrial Fibrilation Symptoms in the Health Related Quality of Life in Spanish Population (Ulises Study)

    Nov 1, 2012, 00:00

  • PCV21 Budget Impact Analysis of Introducing of pCMV-VEGF165 for Treatment of Critical Limb Ischemia From the Russian Health Care System Perspective

    Nov 1, 2012, 00:00

  • PSY4 Studies on Lead Detoxifying Effect of Ascorbic Acid in Traffic Police Subjects of Karachi

    Nov 1, 2012, 00:00

  • PGI15 Comparison of Knowledge, Attitude and Practice Among Hepatitis-B Patients and Healthy Population Regarding Hepatitis-B

    Nov 1, 2012, 00:00

  • PGI12 Assessment of Knowledge, Attitude and Practices of Hepatitis B Patients Towards Their Disease

    Nov 1, 2012, 00:00

  • PHP34 France Market Access- Review of 2011-2012 Assessments by Transparency Committee

    Nov 1, 2012, 00:00

  • PDB1 Real-World Incidence of Hypoglycemia and Associated Costs Among Insulin Glargine-Treated Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PMS47 The Health and Economic Consequences of Delay in Starting Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011

    Nov 1, 2012, 00:00

  • PDB37 Cost-Effectiveness of Adding Twice-Daily Exenatide to Basal Insulin in Patients With Type 2 Diabetes in Scotland

    Nov 1, 2012, 00:00

  • PCV104 Relationship Between Comorbidities, Blood Pressure Control and Therapeutic Schemes in Real-Life Setting Hypertensive Patients

    Nov 1, 2012, 00:00

  • PCN7 Angiotensin-Converting Enzyme Inhibitors Enhance the Effect of Cyclooxygenase Inhibitors on Breast Cancer - A Nationwide Case-Control Study

    Nov 1, 2012, 00:00

  • PIN52 Pharmacoeconomical Aspects of Treating Acute Bronchitis Among Adults

    Nov 1, 2012, 00:00

  • PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants Use

    Nov 1, 2012, 00:00

  • PGI20 Cost-Effectiveness of Adalimumab for Treatment of Crohn's Disease in Germany

    Nov 1, 2012, 00:00

  • PMS81 Cost-Effectiveness and Budget Impact of Certolizumab Pegol Against a Mix of Treatments in an Outcomes-Based Risk-Sharing Scheme in Finland

    Nov 1, 2012, 00:00

  • PMS45 Exercise Therapy, Manual Therapy, or Both, for Management of Osteoarthritis of the Hip or Knee- Economic Evaluation Alongside a Randomized Clinical Trial

    Nov 1, 2012, 00:00

  • PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in China

    Nov 1, 2012, 00:00

  • PMD25 Financial Impact of Adaptive Cardiac Resynchronization Therapy (ACRT) Device Algorithms in the United Kigdom, Germany, Australia and Canada- Are There Savings Associated With Device Selection?

    Nov 1, 2012, 00:00

  • PCV32 A Non-Clinical Randomized Controlled Trial Assessing Impact of Pharmacists Led Intervention Programme for Enhancing Medication Adherence and Health-Related Quality of Life

    Nov 1, 2012, 00:00

  • PUK16 Cost-Effectiveness of Ketosteril Treatment in Stage 3-4 CKD Patients

    Nov 1, 2012, 00:00

  • PMS80 Biologic Therapies for Rheumatoid Arthritis – Eligibility Criteria in the UK

    Nov 1, 2012, 00:00

  • PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in Singapore

    Nov 1, 2012, 00:00

  • PHP11 Availability and Pricing of Innovative Pharmaceuticals in the Top 5 European Pharmaceutical Markets

    Nov 1, 2012, 00:00

  • PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland

    Nov 1, 2012, 00:00

  • PUK6 Comparison of Quality of Life Between Hemodialysis and Peritoneal Dialysis Patients in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PCN30 Treatment Patterns and Outcomes of Breast Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor Country

    Nov 1, 2012, 00:00

  • PRM98 Optimizing Discrete Choice Experiment Designs Using Simulations

    Nov 1, 2012, 00:00

  • PHP204 Appropriate Methods for Economic Evaluation of Programmes with Costs and Effects Extending Across Sectors

    Nov 1, 2012, 00:00

  • PSY43 Utilization of Pain Medications in Patients With Chronic Lower Back Pain Who Initiated Duloxetine or Standard of Care for the Management of Pain

    Nov 1, 2012, 00:00

  • PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund Data

    Nov 1, 2012, 00:00

  • PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents- Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in Taiwan

    Nov 1, 2012, 00:00

  • PMS12 Budget Impact of Golimumab in the Anti-TNF Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

    Nov 1, 2012, 00:00

  • PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in Taiwan

    Nov 1, 2012, 00:00

  • PSY7 Societal Burden Associated With Neuropathic Pain in Europe

    Nov 1, 2012, 00:00

  • PRM122 Atopic Dermatitis on Families- Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PMD2 Hematologic Cancers- Diagnostic Testing Patterns and the Role of Specialty Laboratories in the Age of Personalized Medicine

    Nov 1, 2012, 00:00

  • DU1 A Time Series Analysis of the Effect of the Co-Payment on Pharmaceutical Consumption in Two Italian Regions

    Nov 1, 2012, 00:00

  • PHP11 Time Trends and Determinants of Pharmaceutical Expenditure in China in 1990-2009

    Nov 1, 2012, 00:00

  • PRM68 Comparative Computation Speed of Excel, Visual Basic for Applications, R, and Java in Execution of a Microsimulation Model With Probabilistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy

    Nov 1, 2012, 00:00

  • PRM176 The Value of Further Research- The Added Value of Individual-Level Data

    Nov 1, 2012, 00:00

  • PRM12 Evidence for Validity of a National Patient-Reported Survey in China- The China National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PCV1 Evaluation of Statin-Associated Adverse Events- Analysis of the Incidence and Influence of the Concomitant Use of Potential Interacting Drugs

    Nov 1, 2012, 00:00

  • PR3 Utility Values for Chemotherapy-Related Adverse Events- A Review of the Literature

    Nov 1, 2012, 00:00

  • PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention- A Comparative Effectiveness Study of Clopidogrel and Prasugrel

    Nov 1, 2012, 00:00

  • PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or Adalimumab

    Nov 1, 2012, 00:00

  • PHP14 2010-2012 Global Health Care Reforms and Their Impact on Pricing, Access and Health Outcomes Strategy

    Nov 1, 2012, 00:00

  • PRM12 Joint Estimation of Progression Free Survival and Overall Survival

    Nov 1, 2012, 00:00

  • PRM85 Internal Validation of the Syreon Diabetes Model

    Nov 1, 2012, 00:00

  • PRM36 Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Evolution of Content, Structure, and Functionalities (2002-2012)

    Nov 1, 2012, 00:00

  • PRM17 Economic Evaluation of Vaccines- Considerations on Evidence, Discounting, Models and Futures Challenges

    Nov 1, 2012, 00:00

  • PND16 Qualitative Research Describing Patients' Perspectives of Successful Prophylactic Treatment With Botulinum Toxin Type a for Chronic Migraine

    Nov 1, 2012, 00:00

  • PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care Perspective

    Nov 1, 2012, 00:00

  • PMD49 Cost-Effectiveness of the TLC-NOSF Dressing in Venous Leg Ulcers

    Nov 1, 2012, 00:00

  • PND52 Validation of Spanish Version of the Huntington Clinical Self-Reported Instrument (H-CSRI)

    Nov 1, 2012, 00:00

  • PCN157 Conceptual Framework for the Evaluation of Patient Access Schemes (PAS) in the EU

    Nov 1, 2012, 00:00

  • CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in Oncology

    Nov 1, 2012, 00:00

  • NI2 The Use of Off-Label Comparators in Nice Appraisals – An Indirect Endorsement?

    Nov 1, 2012, 00:00

  • PUK1 Diuretic Activity of Aqueous Extract of Boswellia Serrata Roxb. Oleo Gum in Normal Albino Rats

    Nov 1, 2012, 00:00

  • PMS20 Total Health Care Costs Associated With Rheumatoid Arthritis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PCV34 The Economic Cost of Acute Coronary Syndrome in Turkey

    Nov 1, 2012, 00:00

  • PCV81 Awareness of Serious Consequences of Non-Compliance and Self-Reported Adherence to Antipaltelet Therapy After Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • HC4 Tapping Into the Asian Pharmaceutical Market- Global Firms Go Local?

    Nov 1, 2012, 00:00

  • PDB18 Direct Medical Costs of Diabetes Mellitus in China- Annual Cost of Illness and Long-Term Projections Using a Validated Diabetes Model

    Nov 1, 2012, 00:00

  • PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer

    Nov 1, 2012, 00:00

  • PHP100 Prevention or Treatment? Preferences of the Australian Public for Health Technology Assessment Funding Criteria

    Nov 1, 2012, 00:00

  • PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal Waves

    Nov 1, 2012, 00:00

  • PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study

    Nov 1, 2012, 00:00

  • PMS50 Indirect Costs of Rheumatoid Arthritis in Serbia Related to Work Absenteeism, Medical Welfare and Rehabilitation Costs

    Nov 1, 2012, 00:00

  • UT2 Mapping DLQI on EQ-5D in Psoriasis – Transformation of Skin-Specific Health-Related Quality of Life Into Utilities

    Nov 1, 2012, 00:00

  • PCV68 Economic Evaluation of Initiation With Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension in Spain

    Nov 1, 2012, 00:00

  • PCV62 Clinical and Economic Analysis of the Effectiveness of Antihypoxia Substance Polydihydroxyphenylenethiosulfonate Sodium (Hypoxenum) in the Complex Angina Pectoris Treatment

    Nov 1, 2012, 00:00

  • PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in Germany

    Nov 1, 2012, 00:00

  • PDB63 Improvements in Health-Related Quality of Life in Acromegaly With Pasireotide LAR and Octreotide LAR- Results From a Large, Randomized, Double-Blind Phase III Trial

    Nov 1, 2012, 00:00

  • PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCN119 Patient-Reported Outcomes (PROs) in Antineoplastic Product Approvals in Europe and in the USA

    Nov 1, 2012, 00:00

  • PCV90 A Novel Conceptual Model of Caregiver Burden in Chronic Heart Failure- A Qualitative Study

    Nov 1, 2012, 00:00

  • PSS32 Predictors of Biologic Treatment in Psoriasis Population

    Nov 1, 2012, 00:00

  • PSU29 French Survey on the Management of Anemia and Iron Supplementation in Patients in Elective Orthopedic Surgery

    Nov 1, 2012, 00:00

  • PHP10 The Effect of Law for Economical Use of Medications 2006 on the Average Turnover of Community Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • CV2 Age, Dementia, and Evidence-Based Medication Use After Admission for Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PMH21 Cost-Effectiveness of Intramuscular Ziprasidone for the Treatment of Acute Agitation Associated to Schizophrenia in Mexico

    Nov 1, 2012, 00:00

  • PHS39 Cost-Effectiveness of a Nurse-Led Integrated Chronic Care Approach Versus Usual Care in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PCV52 Cost-Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Portugal

    Nov 1, 2012, 00:00

  • PSS3 The Efficacy of Epidermal Growth Factor in Burn Wound Treatment

    Nov 1, 2012, 00:00

  • PHP117 SMC Decisions- Are They Getting Tougher?

    Nov 1, 2012, 00:00

  • PSY3 Assessing the Cost Effectiveness of Public Health Interventions to Prevent Obesity- A Systematic Review of the Effectiveness of 16 Obesity Prevention Interventions

    Nov 1, 2012, 00:00

  • PRM169 Internal and External Validity in Economic Modeling- Considerations Based on a Published Example

    Nov 1, 2012, 00:00

  • PHP13 The Effect of Law for Economical Use of Medications 2006 on the Number of Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PHS35 The Distribution of Outpatient Physiotherapy Services in Hungary

    Nov 1, 2012, 00:00

  • PCV119 Retrospective Analysis of Pharmaceutical Expenditures in 2011 in the Republic of Srpska

    Nov 1, 2012, 00:00

  • PCN12 Meta Analytic Comparison of Breast Cancer Risk in Diabetic Women- Important Differences Between Asian and Caucasian Women Suggest Risk Management Startegies

    Nov 1, 2012, 00:00

  • PRM133 Reviewing Translatability Prior to Translation and Linguistic Validation of Pros

    Nov 1, 2012, 00:00

  • PSY12 The Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

    Nov 1, 2012, 00:00

  • PCN109 Quality of Life Assessment of Chronic Myeloid Leukemia Patients in Austria- Cross-Sectional Pilot Study Using the EQ-5D

    Nov 1, 2012, 00:00

  • PSU6 Cost-Effectiveness Analysis of Treatment for Rectal Cancer Following Clinical Complete Response

    Nov 1, 2012, 00:00

  • PRM124 Translation of the Alcohol Timeline Followback (TLFB) in 4 Languages

    Nov 1, 2012, 00:00

  • PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in Fran The EQOFIX Study

    Nov 1, 2012, 00:00

  • PCV71 Economic Evaluation of Lipid Lowering Therapy in the Secondary Prevention Setting in the Philippines

    Nov 1, 2012, 00:00

  • PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey

    Nov 1, 2012, 00:00

  • PHP69 Factors May Influence Pattern of Medicine'S Use

    Nov 1, 2012, 00:00

  • PMS38 Cost-Effectiveness of Tapentadol for Severe Chronic Non-Cancer Pain in Belgium

    Nov 1, 2012, 00:00

  • PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in Ukraine

    Nov 1, 2012, 00:00

  • PHP62 Modify Change Order System to Reduce Drug Return Rate in Inpatient Pharmacy

    Nov 1, 2012, 00:00

  • PSS17 Clinical and Economic Analysis of Linezolid for the Treatment of Methicillin Resistant Staphylococcus Aureus Confirmed Complicated Skin and Soft Tissue Infections Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP1 A Qualitative Exploration of Malaysian Cancer Patients' Perceptions Towards Cancer Screening

    Nov 1, 2012, 00:00

  • PRM29 Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI- CHRI) in Germany and Canada

    Nov 1, 2012, 00:00

  • DB3 How a Fear of Hypoglycemia Influences Health-Related Quality of Life in Type 2 Diabetes Mellitus Patients in Spain? Hipoqol-II Study

    Nov 1, 2012, 00:00

  • PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting

    Nov 1, 2012, 00:00

  • PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC)- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PMD76 The Effect of Insulin Pump Therapy on Health Status Among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PCV19 Hospitalization Costs and Their Predictors in Patients With Venous Thromboembolism in China

    Nov 1, 2012, 00:00

  • PSS1 Persistence With Statin Therapy and Risk of Psoriasis- A Population-Based Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PIN24 Clinical and Economic Evaluation of an Adult Pneumococcal Vaccination Programme Aimed at the Spanish HIV Population

    Nov 1, 2012, 00:00

  • PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

    Nov 1, 2012, 00:00

  • PCN108 Quality of Life and Patient Preferences in Platinum Sensitive Ovarian Cancer

    Nov 1, 2012, 00:00

  • PRS40 Are Disease Management Programs for COPD Cost-Saving?

    Nov 1, 2012, 00:00

  • PIN88 Cost Implications of Different Practices in Vaccine Provision

    Nov 1, 2012, 00:00

  • PRM25 First Drive-Through Pharmacy Service in Taiwan

    Nov 1, 2012, 00:00

  • PCN52 English Hospital Costs for Anal Cancer- Preliminary Results from an Investigation Using Hospital Episodes Statistics (HES)

    Nov 1, 2012, 00:00

  • PCV7 Implementing and Evaluating Pharmacist-Managed Warfarin Service in Inpatient and Outpatient Setting in Taiwan

    Nov 1, 2012, 00:00

  • PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in Taiwan

    Nov 1, 2012, 00:00

  • PRS15 The Economic Impact of COPD in Patients of Working Age- Results From ‘COPD Uncovered' the Netherlands

    Nov 1, 2012, 00:00

  • PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-Depressants

    Nov 1, 2012, 00:00

  • PHP44 Public Financing of Medicines in Portugal (2007-2011)- Accessibility to Medicinal Products with New Molecules or New Therapeutic Indications

    Nov 1, 2012, 00:00

  • PSU13 Survival and Cost Comparison of Balloon-Kyphoplasty and Vertebroplasty Using German Claims Data

    Nov 1, 2012, 00:00

  • PHP120 New Pricing Dynamics in Big Five EU- Case Study of Biosimilar GM-CSF Products

    Nov 1, 2012, 00:00

  • PHS92 Allocation of Research Funding in Health Care in Relation to Disease Burden in Europe

    Nov 1, 2012, 00:00

  • PHP111 Development of National Medicine Brand Substitution Guidelines and Pilot Assessment of Its Adoptability among Community Pharmacist and General Practitioners in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • PRM146 An Excel Calculator Tool to Perform Meta-Analysis

    Nov 1, 2012, 00:00

  • PIN3 Burden of Cytomegalovirus Disease in Immunosuppressed Persons Following Transplantation in France

    Nov 1, 2012, 00:00

  • PHP77 Health Expenditure and Drug Expenditure - Comparison of Two Western Balkans Countries

    Nov 1, 2012, 00:00

  • PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in Japan

    Nov 1, 2012, 00:00

  • PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation

    Nov 1, 2012, 00:00

  • PND13 Old and New Antiepileptic Drugs Utilization in Iran

    Nov 1, 2012, 00:00

  • PHP69 United States Valuation of Child Health Outcomes

    Nov 1, 2012, 00:00

  • MA2 Observation of Persistence Rates and Potential Cost Savings Associated With Certolizumab Pegol Treatment for Rheumatoid Arthritis in England, Wales and Northern Ireland Clinical Practice

    Nov 1, 2012, 00:00

  • PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With Duloxetine

    Nov 1, 2012, 00:00

  • PRM151 Collapsibility and Censoring- What's the Bias in Estimated Survival Time?

    Nov 1, 2012, 00:00

  • PIN17 Tuberculosis Treatment Outcomes in Four States of Malaysia

    Nov 1, 2012, 00:00

  • PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009

    Nov 1, 2012, 00:00

  • PMD30 Short Term Health-Economic Outcomes of Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes- A Cost Comparison Analysis

    Nov 1, 2012, 00:00

  • PHS40 An Example of Irrational Decision Making in the Elderly- Why are Pharmacological Therapies Preferentially Reimbursed Over Non-Pharmacological Therapies for Insomnia?

    Nov 1, 2012, 00:00

  • PSU21 Sentinel Lymph Node Biopsy Less Expensive Than Axillary Lymph Node Dissection in Early Breast Cancer Staging

    Nov 1, 2012, 00:00

  • PUK19 Antimuscarinic Persistence Patterns in Newly Treated Patients With Overactive Bladder (OAB)- Retrospective Comparative Analysis of Fesoterodine, Solifenacin and Tolterodine

    Nov 1, 2012, 00:00

  • PHS97 An Off-the-Shelf Catalogue of Quality Improvement Interventions to Implement in the Prevention of Pressure Ulcers for Hospital Settings

    Nov 1, 2012, 00:00

  • PHP115 Geographical Distribution of Pharmacies Versus Population- The Case of Two Capital Cities in Iran

    Nov 1, 2012, 00:00

  • PHP173 Disentangling the Relationship Between Disability, Socioeconomic Status and Social Capital in Chile- A Population-Based Study

    Nov 1, 2012, 00:00

  • PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)

    Nov 1, 2012, 00:00

  • PDB30 The Prevalence and Burden of Comorbid Hypertension and Obesity among Patients With Type 2 Diabetes in Japan

    Nov 1, 2012, 00:00

  • PSY36 Changes in Pain Intensity and Health Related Quality of Life (QoL) in Patients With Peripheral Neuropathic Pain After a Single Treatment of 8% Capsaicin Patch – Results From a Swedish 12 Week Prospective Observational Study

    Nov 1, 2012, 00:00

  • PCV19 The Burden of Diabetes Mellitus in Belgium- A Retrospective Database Study

    Nov 1, 2012, 00:00

  • CL4 Drug Switching Events Among Users of NSAIDS With or Without Gastro-Protective Drugs As an Early Determinant of Dissatisfaction From Gastrointestinal Adverse Events

    Nov 1, 2012, 00:00

  • PMD41 Economic Evaluation of Continuous Subcutaneous Insulin Infusion for Children With Diabetes – a Pilot Study

    Nov 1, 2012, 00:00

  • DB2 Vitamin D Deficiency and Diabetes- Perceptions of Pharmacists and Physicians

    Nov 1, 2012, 00:00

  • PMH17 Economic Burden in Schizophrenia- A Literature Review

    Nov 1, 2012, 00:00

  • PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)

    Nov 1, 2012, 00:00

  • PGI7 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapies in Ulcerative Colitis (UC)- A UK Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PMH41 A Change of Dysuria, Xerostomia, Anxiety and Depression After Initiation of Inhaled Drugs

    Nov 1, 2012, 00:00

  • PMH51 Real World Add-on and Switch Patterns for Different Formulation of Methylphenidate

    Nov 1, 2012, 00:00

  • PCN75 Survival and Costs in Metastatic Renal Cell Carcinoma- A Comparison of mRCC Treatment Pre- and Post Tyrosine Kinase Inhibitor (TKI) Introduction Using Retrospective Registry Data

    Nov 1, 2012, 00:00

  • PHP22 Pharmacovigilance in Qatar – a Pharmacist Survey

    Nov 1, 2012, 00:00

  • PGI14 Characteristics of Diverticulitis-Related Emergency Department Visits in the United States

    Nov 1, 2012, 00:00

  • PRM74 Cost Effectiveness of Tirofiban in Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PMS8 The Mortality and Costs from Hip, Vertebral, Wrist and Other Fractures Among Postmenopausal Women in Taiwan

    Nov 1, 2012, 00:00

  • PSU14 Economic Impact of Scoliosis in Canada- A RAMQ Database Analysis

    Nov 1, 2012, 00:00

  • RU1 Cholinesterase Inhibitors- A Population-Based Assessment of Resource Utilization and Costs for Patients With Alzheimer'S Dementia

    Nov 1, 2012, 00:00

  • PCN121 Decitabine Reduces Transfusion Dependence in Older Patients With Acute Myeloid Leukaemia- Results From a Post-Hoc Analysis of a Randomised Phase III Trial

    Nov 1, 2012, 00:00

  • PMS21 Functional Impairment, Disease Activity, and Duration of Disease Independently Affect the Quality of Life in Patients with Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCV122 Hypertension and Disability-Free Life Expectancy From a Cohort Study in Japan –Results From a Nationwide Cohort Study (NIPPON DATA80/90)

    Nov 1, 2012, 00:00

  • PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate- A Pharmacovigilance Analysis of the Adverse Event Reporting System

    Nov 1, 2012, 00:00

  • PCN28 Statin Use and Risk of Breast Cancer- A Meta-Analysis of 24 Observational Studies

    Nov 1, 2012, 00:00

  • PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc)- Analysis of Prescription Claims From the Ramq Database

    Nov 1, 2012, 00:00

  • PHS71 Health Related Quality of Life of HIV Patients at a Tertiary Care Hospital in Bangalore

    Nov 1, 2012, 00:00

  • PRM125 Whose Values in Health? A Comparison of Adult and Adolescent Values for the CHU9D and AQOL-6D

    Nov 1, 2012, 00:00

  • PHP59 Exploring the Health and Living Standards of Those Who Don't Report Their Migration Status in a Population-Based Survey- The Case of Chile

    Nov 1, 2012, 00:00

  • PMS58 Frequency of Administration of Biologics has an Impact on Treatment Decision Making

    Nov 1, 2012, 00:00

  • PCV86 The Burden of Non-Adherent Prescription Cost Cutting Among Diagnosed Hypertension Patients in Russia

    Nov 1, 2012, 00:00

  • PCN105 Impact of Pharmacy Channel on Abandonment Rate of Oral Oncolytics

    Nov 1, 2012, 00:00

  • PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported Outcomes

    Nov 1, 2012, 00:00

  • PCN31 A Cross-Sectional Assessment of the Quality of Life of Cancer Patients and Their Complementary and Alternative Medicines (CAM) Use

    Nov 1, 2012, 00:00

  • PMH24 Cost of Long-Acting Risperidone Injection Versus Long-Acting Paliperidone Palmitate in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • RE1 Factors Influencing Drug Reimbursement Decision in Scotland

    Nov 1, 2012, 00:00

  • PMD5 Clinical and Cost-Effectiveness of Third-Generation, Implantable Left Ventricular Assist Devices for People With End-Stage Heart Failure- A Systematic Review

    Nov 1, 2012, 00:00

  • PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal

    Nov 1, 2012, 00:00

  • PMS66 The Myotonic Dystrophy Type-1 Health Index (MDHI)- An Analysis of its Ability to Differentiate Between Clinically Distinct Populations

    Nov 1, 2012, 00:00

  • PHS53 Use of Health Care Administrative Databases to Estimate the Burden of Multiple Sclerosis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PUK7 Cost of Illness of Overactive Bladder Syndrome in Hungary

    Nov 1, 2012, 00:00

  • RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion- Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites

    Nov 1, 2012, 00:00

  • PMD60 The Costs-Effectiveness of 3M™ CobanTM 2 Layer Compression System (Coban 2) for the Treatment of Lymphoedema in the Netherlands

    Nov 1, 2012, 00:00

  • PHP176 Socioeconomic Inequalities Concerning the Self-Rated Health Status in Gree A Comparative Analysis of Post-Crisis Effects

    Nov 1, 2012, 00:00

  • PCN147 A Cross European Comparison of Eribulin Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PA1 Assessing the Progression of the UK NHS Health Care Reforms and the Impact on Health Care Delivery

    Nov 1, 2012, 00:00

  • PSS8 Non-Interventional Study on the Burden of Illness in Diabetic Macular Edema (DME) in Belgium

    Nov 1, 2012, 00:00

  • PIH9 Compare Health Care Utilization and Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims Database

    Nov 1, 2012, 00:00

  • PIH4 Network Meta-Analysis of Pharmacological Interventions to Prevent Venous Thromboembolism Following Elective Knee and Hip Replacement Surgery- Why Extend the Network?

    Nov 1, 2012, 00:00

  • PUK17 Cost-Mimimization Analysis of Pazopanib Versus Sunitinib, Sorafenib and Bevacizumab+ Interferon á-2a for Patients With Metastatic Renal Cell Carcinoma

    Nov 1, 2012, 00:00

  • PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis

    Nov 1, 2012, 00:00

  • PMS20 Patients Reported Outcomes in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated With Golimumab- Sub-Analysis of Asia Population Enrolled in Multicentre Phase Iii Clinical Trials

    Nov 1, 2012, 00:00

  • PHP182 Concordance of PRO Labeling Claims Between the FDA and EMA

    Nov 1, 2012, 00:00

  • PRM6 The UK Contribution to Real World Research- Review of Published Data at ISPOR, Madrid 2011

    Nov 1, 2012, 00:00

  • PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the U ...

    Nov 1, 2012, 00:00

  • PSU17 The Cost of Surgical Procedure to Remove Adhesions Abdomen or Pelvis in the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP109 Practice Change in Italian Community Pharmacy- An Analysis of Managerial Implication

    Nov 1, 2012, 00:00

  • PND15 Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) Compared to Benzodiazepines for the Treatment of Acute Prolonged Epileptic Seizures in Germany

    Nov 1, 2012, 00:00

  • PND54 Fatigue and Quality-of-Life in Multiple Sclerosis Patients With Spasticity in Germany - Results of the Move 1 Study

    Nov 1, 2012, 00:00

  • PMD69 Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation in the UK

    Nov 1, 2012, 00:00

  • PHP67 Review of the Currently Listed Drugs in South Korea

    Nov 1, 2012, 00:00

  • PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple Myeloma

    Nov 1, 2012, 00:00

  • PRM166 The Challenge of Assessing Health Technologies Early in the Development. Systematic Literature Review of Methods in Use

    Nov 1, 2012, 00:00

  • PHP99 Implementation of a Formulary Management Programme in Singapore

    Nov 1, 2012, 00:00

  • PHP111 Factors Predicting Reimbursement Decisions on Orphan Drugs in Eight Countries

    Nov 1, 2012, 00:00

  • PCV9 Association Between Persistence With Statins and Reduction of Low Density Lipoprotein Cholesterol- Analysis of Real-Life Data from Community Settings

    Nov 1, 2012, 00:00

  • CV3 Real-World Characterization of Hypertension Patients in Japan- A 1-Year Overview

    Nov 1, 2012, 00:00

  • PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort- A Brazilian Health Management Organization Experience

    Nov 1, 2012, 00:00

  • PMD91 Scenario Analysis and Real Options Modeling of Home Brain Monitoring in Epilepsy Patients

    Nov 1, 2012, 00:00

  • PHP12 Patented Drug Extension Strategies on Health Care Spending- A Cost-Evaluation Analysis

    Nov 1, 2012, 00:00

  • PND47 Assessment of Quality of Life of Australians With Young Onset Parkinson's Disease

    Nov 1, 2012, 00:00

  • PCN145 Observational Macro Analysis on the Aggregated Cigarette Price Elasticity in Denmark 1978-2010

    Nov 1, 2012, 00:00

  • PHS2 Population Risk Stratification- Based on the Cost of Care in Patients With Chronic Diseases

    Nov 1, 2012, 00:00

  • PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy

    Nov 1, 2012, 00:00

  • PCV11 Indirect Treatment Comparison (ITC) of Novel Oral Anticoagulants for the Prevention of Thromboembolic Events in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PND14 Budgetary Impact of the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece

    Nov 1, 2012, 00:00

  • PIH23 A Discrete Event Simulation Model Used for Pharmacoeconomic Evaluation of Omegaven® in the Chinese Setting

    Nov 1, 2012, 00:00

  • PRM93 Infantile Hemangioma on Families,Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PHP3 Adherence to the Clinical Practice Guidelines in the Management of Chronic Ischemic Heart Failure in a District Hospital

    Nov 1, 2012, 00:00

  • PCV32 The Cost of Diabetes Complications in Belgium

    Nov 1, 2012, 00:00

  • PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in Ireland

    Nov 1, 2012, 00:00

  • PCV25 Hospitalization Costs of Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention- Comparison Between Clopidogrel and Prasugrel Patients in a United States Hospital Database

    Nov 1, 2012, 00:00

  • PRM30 Hospitalization Registry and Costs of Benign Prostatic Hyperplasia Patients (BPH) Based on a Public Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • PSY16 Cost Utility Analysis of Reduced Intensity Hematopoietic Stem Cell Transplantation in Adolescence and Young Adult With Severe Thalassemia Compared to Hypertransfusion and Iron Chelation Program

    Nov 1, 2012, 00:00

  • PRM46 Development of a Framework for Cost-Effectiveness Analysis Cohort Simulation Using an Ordinary Differential Equation Solver Algorithm in R

    Nov 1, 2012, 00:00

  • PMS7 Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients With Rheumatoid Arthritis Aged 50 Years and Over

    Nov 1, 2012, 00:00

  • PUK9 Direct and Indirect Cost of Urge Urinary Incontinence With and Without Pharmacotherapy

    Nov 1, 2012, 00:00

  • PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central Europe

    Nov 1, 2012, 00:00

  • PIH1 Spontaneous Adverse Drug Reactions Reporting Forms of 55 Different Countries – Evaluation, Comparison, and Quality Check

    Nov 1, 2012, 00:00

  • PRM155 A Pragmatic Randomized Clinical Trials – Design and Quality Assessment of the Source of Effectiveness Data

    Nov 1, 2012, 00:00

  • PDB12 How Hypoglycaemic Events Can Influence Diabetic Patients' Weight and Affect Hba1C Control

    Nov 1, 2012, 00:00

  • PIH33 Utility and Human Capital Loss in Asthma, Chronic Obstructive Pulmonary Disease and Rheumatoid Arthritis – The Impact of Prevalence, Disease Specific Mortality and Utility Decrement on Overall Health Burden

    Nov 1, 2012, 00:00

  • PDB73 Obesity and Frequent Hypoglycemia in European Type 2 Diabetes Patients

    Nov 1, 2012, 00:00

  • PIN51 Health Economic Evaluation of the Vaccination Against Herpes Zoster and Postherpetic Neuralgia in Germany

    Nov 1, 2012, 00:00

  • PDB58 The Psychometric Performance of the EQ-5D, SF-6D and Diabetes Health Profile (DHP-18) in Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PHS31 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Musculoskeletal and Connective Tissue Diseases

    Nov 1, 2012, 00:00

  • PHP62 A Novel Global Health Drug Subsidy AMFm- Assessment of Deployment in Southern Ghana

    Nov 1, 2012, 00:00

  • PIH46 Outcomes of Drug Use During Pregnancy- A Novel Database in the Netherlands to Study Drugs Risk on the Yet Unborn

    Nov 1, 2012, 00:00

  • PIN55 How Should We Target Cost-Efficacy in the Treatment of HIV-1 Naïve Patients With Recommended Therapies Based on NNRTIS in Spain?

    Nov 1, 2012, 00:00

  • PCV106 Affordability of Anti-Hypertensive Medication in Egypt Under Current Reimbursement Systems

    Nov 1, 2012, 00:00

  • PCN139 Characteristics of Long-Acting Somatostatin (SSA) Use in Gastro-Entero-Pancreatic Neuroendocrine (GEP-NET) Tumors in the Netherlands

    Nov 1, 2012, 00:00

  • PMS22 Improvement on Quality of Life and Daily Function in Rheumatoid Arthritis Patients Treated with Infliximab in China

    Nov 1, 2012, 00:00

  • PMS17 The Societal Cost for RA Before and After the Introduction of Biological Drugs- a Swedish National Register Study for 1990-2010

    Nov 1, 2012, 00:00

  • PMH3 Caregiver Perceptions on the Burden of Caring for Dementia Patients- Results from a Cross-Sectional Hospital-Based Study in China

    Nov 1, 2012, 00:00

  • PCN124 Lost Productivity in Population of Cancer Patient's Close Relatives in Poland

    Nov 1, 2012, 00:00

  • PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PSU4 Regional Variation in Angiogram Use for Patients Who Underwent Coronary Artery Bypass Graft Surgery

    Nov 1, 2012, 00:00

  • PMS1 Characteristics of Patients With Rheumatoid Arthritis in Turkey- Results from the Turkish League Against Rheumatism RA Registry

    Nov 1, 2012, 00:00

  • PIH9 Assosiation Between Health Care Providers and Immunization Compliance in Iraq

    Nov 1, 2012, 00:00

  • PND19 Pharmacological Costs of Recurrent-Remitent Multiple Sclerosis Treatment in Spain

    Nov 1, 2012, 00:00

  • PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

    Nov 1, 2012, 00:00

  • PHP177 Characteristics of Patients Not Consuming Pharmacological Resources Due to a Lack of Drug Prescription During Their Hospital Admission

    Nov 1, 2012, 00:00

  • PDB27 Cost-Utility Analysis of Liraglutide Versus Glimepiride As Add-on to Metformin in Patients with Type 2 Diabetes in China

    Nov 1, 2012, 00:00

  • PRM30 Evaluating Readiness for Work in Patients With Schizophrenia- “The Readiness for Work Questionnaire” (WoRQ)

    Nov 1, 2012, 00:00

  • NI1 Three Years of Nice Scientific Advi Comprehensive Analysis of Requests to the Programme

    Nov 1, 2012, 00:00

  • PRM138 A Propensity to Get It Right. A Monte Carlo Simulation Study Comparing Statistical Methods to Obtain Correct Cost-Effectiveness Estimates in Observational Studies

    Nov 1, 2012, 00:00

  • PRM153 Prioritizing Multiple Patient-Relevant Endpoints - a Methodological Comparison of Conjoint Analysis and Analytic Hierarchy Process Considering IQWiG‘s Efficiency Frontier Concept

    Nov 1, 2012, 00:00

  • PCN142 Success Factors for Achieving Reimbursement for Oncology Drugs in Australia

    Nov 1, 2012, 00:00

  • PRM167 The Value of Choice in a Collectively Funded Health System- An Extended Analytical Approach to Examine the Conflict Between Decisions at Individual and Societal Level

    Nov 1, 2012, 00:00

  • PCV80 A Retrospective Study of Comparing Compliance and Persistence of Free Combination Antihypertensive Therapy Versus Single-Pill Combination- Korean Case

    Nov 1, 2012, 00:00

  • PHS26 Economic Burden of Seasonal Influenza B in France During Winter 2010-2011

    Nov 1, 2012, 00:00

  • PRM20 Construction of the Markov Model for Hepatitis B Virus Related Diseases in Japan

    Nov 1, 2012, 00:00

  • PND68 Comparison of Hospitalizations Among Parkinson'S Patients Who Initiated Therapy With a Dopamine Agonist or Rasagiline- Evidence From the Medicare Supplemental Database

    Nov 1, 2012, 00:00

  • PHP106 Diffusion of Non-Guideline Experience-Based Chemotherapy Care

    Nov 1, 2012, 00:00

  • PRM8 Treatment of Rheumatoid Arthritis – Comparative Effectiveness of Biologics

    Nov 1, 2012, 00:00

  • PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus Patients

    Nov 1, 2012, 00:00

  • PHP188 Funding the Unfundable- The Australian Approach for Specialty Pharmaceuticals

    Nov 1, 2012, 00:00

  • PMS18 Importance of COI Studies in the Health Care-Related Decision-Making Process Through the Example of Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PDB50 Health Care Resource Utilization in the Management of Cushing Disease- An Analysis From South-Western Ontario

    Nov 1, 2012, 00:00

  • PMD54 Trans-Catheter Aortic Valve Implantation for the Non-Operative Management of Aortic Stenosis- A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PRM171 Optimal Shopping- An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PHP86 Cost-Effectiveness in Health Care Programs- A Literature Review

    Nov 1, 2012, 00:00

  • PUK2 Economic Burden of Hemodialysis and Peritoneal Dialysis in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PSY47 The Relationship Between Pain Severity and Health Utilities- Informing Clinical Trial Design to Substantiate Value

    Nov 1, 2012, 00:00

  • PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim Data

    Nov 1, 2012, 00:00

  • PCN58 Health Economic Impact of Colorectal Cancer

    Nov 1, 2012, 00:00

  • PCN70 The Cost Effectiveness of Degarelix for the Treatment of Prostate Cancer in the UK

    Nov 1, 2012, 00:00

  • PSY25 Etanercept in Early Rheumatoid Arthritis- Economic Evaluation From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PMD27 Budget Impact of Selecting Cardiac Resynchronization Therapy (CRT) Devices With Adaptive (“ACRT”) Programming Algorithms Under the United States Medicare Payment Setting

    Nov 1, 2012, 00:00

  • PCV115 Burden of Hypertension in Selected EU Countries- 2010-2025

    Nov 1, 2012, 00:00

  • PHP38 Point-of-Care Diagnostic Test Reimbursement and Market Access- Lessons from a Survey of Global Health Technology Assessments

    Nov 1, 2012, 00:00

  • PND9 Frequency and Impact of Relapses in German Patients With Multiple Sclerosis Based on a Longitudinal Population-Based Study

    Nov 1, 2012, 00:00

  • CA4 A Comparison of Patient and General-Population Utility Values for Advanced Melanoma in Health Economic Modelling

    Nov 1, 2012, 00:00

  • PDB24 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Diabetic Peripheral Neuropathy

    Nov 1, 2012, 00:00

  • PIN41 Cost-Effectiveness of Pertussis Adolescent Booster in England and Wales- A Dynamic Model Based Analysis

    Nov 1, 2012, 00:00

  • PSY44 A Cost Effectiveness Model for the Myeloplastic Disease in Greece. Azacitidine Versus Conventional Care Regimens

    Nov 1, 2012, 00:00

  • PMD79 A Population-Based Study on the Use of Blood Glucose Monitoring Test Strips

    Nov 1, 2012, 00:00

  • PCV117 A Ten Years Longer Life- A Therapeutic Education Program for Hypertensive Patients

    Nov 1, 2012, 00:00

  • PCV22 A Simple Risk Score Identifies Individuals, in European Settings, More Likely to Incur Higher Medical Costs

    Nov 1, 2012, 00:00

  • PMD53 Modeling the Health and Economic Conseqences of Self-Monitoring of Blood Glucose (SMBG) in Non-Insulin Treated Patients With Type 2 Diabetes Mellitus (T2DM) in Spain

    Nov 1, 2012, 00:00

  • PGI9 Analysis of Adherence With Oral 5-Aminosalicylic Acid (5-ASA) Therapy in Patients with Ulcerative Colitis (UC) in a Uk Pharmacy Database

    Nov 1, 2012, 00:00

  • ME2 Validation of the Kidney Disease and Quality of Life Questionnaire (KDQOL-36) in Haemodialysis Patients in Singapore

    Nov 1, 2012, 00:00

  • PHP97 The Regional Distribution of Disabled Pensioners of Hungary

    Nov 1, 2012, 00:00

  • PMD23 Long-Term Clinical Effectiveness and Cost-Effectiveness of Catheter-Based Renal Denervation in the UK. A Model-Based Projection Based on the Symplicity HTN-2 Trial

    Nov 1, 2012, 00:00

  • PUK6 The Economic Burden of Post-Transplant Events in Renal Transplant Patients in Germany (The Portrait Study)

    Nov 1, 2012, 00:00

  • PMS14 Impact of Severity Index for Rheumatoid Arthritis on Health Care Costs and Utilizations in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PDB71 Patient Access, Hba1C Knowledge, and Health Outcomes Among Type 2 Diabetes Patients in Brazil

    Nov 1, 2012, 00:00

  • PCN17 Predicting the Potential Cost and Effects of Prophylactic HPV Vaccination in Males in Thailand

    Nov 1, 2012, 00:00

  • PRS37 Quality of Life in Paediatric Asthma From Patient and Their Parents Perspective

    Nov 1, 2012, 00:00

  • PIH30 Potentially Inappropriate Prescribing and Adverse Health Outcomes in Community Dwelling Older Populations

    Nov 1, 2012, 00:00

  • PHP46 Trends in Prevalence of Drug Use among Dutch Children from 2005 Until 2010

    Nov 1, 2012, 00:00

  • ISPOR 5th Asia-Pacific Conference Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PHP144 Economic Effect of Clinical Trials for Turkey

    Nov 1, 2012, 00:00

  • PRM56 Development of a Conceptual Model for Use in Economic Modelling of Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PSU2 The Incidence of Complications After its Thyroidectomy in Patients With Thyroid Cancer in Korea - Using Health Claim Database

    Nov 1, 2012, 00:00

  • PMH11 The Cost-Effectiveness of Risperidone Long-Acting Injection in Schizophrenia Treatment- A Systematic Review

    Nov 1, 2012, 00:00

  • PMS78 Demographİc and Socİoeconomİc Characterİstİcs That Affect Selectİon of İntravenous Versus Subcutaneous İnjectİon Tumor Necrosis Factor Inhİbitors for Rheumatoid Arthritis Patients

    Nov 1, 2012, 00:00

  • PMH8 A Review of Consequences of Relapse in Schizophrenia

    Nov 1, 2012, 00:00

  • PHP167 The Role of Decision-Analytic Modeling in German Health Technology Assessments

    Nov 1, 2012, 00:00

  • PRS17 Availability, Affordability and Price of Asthma Medicines in Tehran; Iran

    Nov 1, 2012, 00:00

  • PRM105 Predicting Subjective Antimuscarinic Effectiveness on Symptoms of Overactive Bladder Using the Eight-Item Overactive Bladder Awareness Tool (OAB-V8)

    Nov 1, 2012, 00:00

  • PHP136 Generic Price Linkage As a Policy Choi Review of Recent Developments

    Nov 1, 2012, 00:00

  • PCN114 Defining Regulatory Success for Patient-Reported Outcomes (PROs) in Oncology

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115 (current)
  • 116
  • 117
  • 118
  • 119
  • 120
  • »